Valgen Medtech’s DragonFly System Gains EU Approval for Functional Mitral Regurgitation
China-based Valgen Medtech has announced that its proprietary DragonFly Transcatheter Mitral Valve Repair System has received CE mark approval in the European Union for the treatment of Functional Mitral Regurgitation (FMR). The latest approval follows the device’s EU authorization for Degenerative Mitral Regurgitation (DMR) in April 2025, making DragonFly the first transcatheter mitral valve repair […]

